| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Ambit Biosciences (AMBI) | Citigroup/ Leerink Swann | $57.50 | n.a. | |||
| RCS Capital (RCAP) | Ladenburg Thalmann/ Realty Capital Securities | $86.25 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| UBIC (UBIC) | Maxim Group/ The Benchmark Company | $46.25 | n/c | |||
| n/c (no call) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Feb. 18, 2013 | Manager(s) | Offered | Raised | Price | 2/22/13 | Change |
| None | ||||||
